NEW YORK (GenomeWeb News) – Cancer diagnostics firm AnalizaDx and informatics company Global Health Management Informatics today announced a licensing agreement to offer AnalizaDx's tests in Africa and the Caribbean.

GHMI will start offering the tests in Nigeria and South Africa. Through a network of hospitals and clinical laboratories with which it collaborates, the Houston-based firm will begin offering AnalizaDx's PSA/SIA, a prostate cancer test, which can differentiate the cancer from other benign conditions using a blood sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.